Related by context. All words. (Click for frequent words.) 69 Neck Cancers 69 Neck Oncology 65 Pancreatic Cancer 65 Bladder Cancer 65 Liver Disease 65 Pulmonary Hypertension 63 Multiple Myeloma 63 Lung Cancer 62 Myeloma 62 Renal Cell Carcinoma 62 Autoimmune Diseases 61 Malignant Melanoma 61 Colorectal Cancer 61 Movement Disorder 61 Malignant Mesothelioma 61 Myelodysplastic Syndromes 61 Prostate Cancer 61 Thyroid Cancer 61 Chronic Lymphocytic Leukemia 61 Gastric Cancer 61 Prostate Cancer Screening 60 Gastrointestinal Oncology 60 Leukemia Lymphoma 60 Stem Cell Transplant 60 Squamous Cell Carcinoma 60 Liver Cancer 60 Colon Cancer 60 Lung Cancer Patients 60 Gynecological Cancer 60 Cancer Immunotherapy 60 Ovarian Cancer Patients 60 ASCO Breast Cancer 59 Autoimmune Disease 59 Neuroendocrine Tumor 59 Sarcoma 59 Biological Therapy 59 Acute Stroke 59 Breast Cancer Patients 59 Esophageal Cancer 59 Metastatic Prostate Cancer 59 Prostate Cancer Treatment 59 Breast Cancer Treatment 59 Bone Marrow Transplant 59 Oncologic 59 Colorectal 58 Hematology Meeting 58 Cardiovascular Therapeutics 58 Pulmonary Fibrosis 58 Cancer Therapy 58 Breast Cancer 58 Wilmot Cancer 58 Acute Heart Failure 58 Breast Cancer Detection 58 Colorectal Cancer Screening 58 Neoadjuvant 58 Neuropathic Pain 58 Hepatocellular Carcinoma 58 Cardiovascular Diseases 58 Sidney Kimmel Cancer 58 Scleroderma 58 Hormone Refractory Prostate Cancer 58 Neuro Oncology 58 Immunodeficiencies 58 Clinical Trial Results 58 Hematologic 58 Thoracic Oncology 58 Cancer Screening 58 Brain Tumors 58 gastrointestinal cancers 58 Renal Cancer 58 Advanced Melanoma 58 Improved Survival 58 Advanced Prostate Cancer 58 Hepatocellular Carcinoma HCC 58 ASCO GI 57 Bone Marrow Transplantation 57 Liver Metastases 57 Medical Oncology 57 Radiosurgery 57 Heart Failure Patients 57 Hematologic Malignancies 57 Cancer 57 Systemic Sclerosis 57 Gastrointestinal Cancers 57 Soft Tissue Sarcoma 57 Bipolar Disorders 57 Stomach Cancer 57 Advanced Renal Cell 57 Liver Diseases 57 Genetic Disorders 57 Cell Transplant 57 Peripheral Arterial Disease 57 Pediatric Epilepsy 57 Radiation Treatment 57 ECTRIMS 57 Vascular Disease 57 Targeted Therapies 57 Rectal Cancer 57 Chronic Myeloid Leukemia 57 Urologic Oncology 57 Colorectal Cancer CRC 57 Prenatal Diagnosis 57 Brentuximab Vedotin SGN 57 Breast Cancer Recurrence 57 Gastrointestinal Cancer 57 Cardiotoxicity 57 Stent Thrombosis 57 Multicenter Study 57 Multiple Sclerosis 57 Breast Reconstruction 57 Brain Tumor 57 Patients Treated With 57 Hematological 57 Therapeutic Targets 57 Cancer Treatments 57 Trigeminal Neuralgia 57 Cardiac Arrhythmias 57 Prostate Cancers 57 Metastatic Breast Cancer 57 Minimally Invasive Treatment 57 Carcinoid 57 Brain Metastases 57 Oral Fingolimod 57 Surgical Treatment 57 Kidney Transplant Patients 57 Cancers Symposium 56 SABCS 56 Metastatic 56 Newly Diagnosed Multiple Myeloma 56 Cancer EORTC 56 Metastatic Colorectal Cancer 56 Neuro Oncology SNO 56 Neoplasia 56 Early Diagnosis 56 Severe Sepsis 56 Marrow Transplant 56 IL# PE#QQR 56 Ovarian Cancer 56 Cutaneous T 56 Cancer Patients Treated 56 Peripheral Artery Disease 56 Rheumatoid Arthritis Patients 56 Metastatic Melanoma 56 ASH Annual Meeting 56 Breast Cancer Survival 56 Diabetic Patients 56 Limb Salvage 56 Prostrate Cancer 56 Cancer Therapies 56 Cancer iSBTc 56 Metabolic Disease 56 Iron Overload 56 ASM Biodefense 56 Gynecologic 56 Novel Therapies 56 Combination REOLYSIN R 56 Interstitial Cystitis 56 Severe Asthma 56 Urinary Incontinence 56 Hematological Malignancies 56 Bone Marrow Transplants 56 Lung Cancer Survival 56 Liver Failure 56 Uterine Fibroid 56 recurrent glioma 56 Clinical Outcome 56 Survivorship Program 56 Therapeutics TCT scientific 56 Colorectal Cancer Patients 56 Metabolic Disorders 56 Vulnerable Plaque 56 Solid Tumors 56 AACR IASLC Joint 56 Aggressive Reduction 56 EORTC 56 Novel Therapeutics 56 Stereotactic Body Radiation Therapy 56 Orphan Diseases 56 Obesity Surgery 56 metastatic colorectal 56 ASCO GU 56 Postmenopausal Women 56 Improves Outcomes 56 Urologic 56 Therapeutic Vaccines 55 Chronic Heart Failure 55 Investigational Treatment 55 Diabetic Foot 55 Vasculitis 55 Naive Patients 55 HCV Protease Inhibitor 55 Genitourinary 55 Overactive Bladder 55 HER2 Positive Breast Cancer 55 Mantle Cell Lymphoma 55 Medical Oncology ESMO 55 Inflammatory Bowel Diseases 55 Adjuvant Therapy 55 Preclinical Study 55 Unresectable 55 Pediatric Hematology Oncology 55 Acute Myocardial Infarction 55 Breast Ultrasound 55 UAB Comprehensive Cancer 55 Survival Benefit 55 Metastases 55 Lung Cancer Trial 55 Anticancer Drug 55 Bipolar Depression 55 Immunotherapeutic 55 Glufosfamide 55 Inflammatory Disease 55 Thromboembolic 55 Platelet Inhibition 55 Hormone Receptor Positive 55 ESMO 55 Anthracycline 55 Biomarker Discovery 55 Lung Cancers 55 HER2 Positive 55 Interventional Radiologists 55 Inflammatory Bowel Disease 55 Patient Outcomes 55 Study Shows Promise 55 Preclinical Studies 55 Lung Cancer Screening 55 Mitochondrial Disease 55 Emerging Therapies 55 Kidney Disease 55 Robotic Prostatectomy 55 Developmental Therapeutics 55 Thyroid Disease 55 Pharmacogenetics 55 Sexual Dysfunction 55 Malignancies 55 Breast Cancers 55 Heart Failure Treatment 55 Ischemic Stroke 55 Autologous Stem Cell Transplantation 55 Chronic Myelogenous Leukemia 55 Uterine Fibroids 55 Stem Cell Treatment 55 Phase III Trial 55 Neoplasms 55 Sipuleucel T 55 Pooled Analysis 55 Cardiovascular Outcomes 55 Cardiac Arrhythmia 55 Male Infertility 55 Prostatic 55 Adjuvant Chemotherapy 55 Targeted Anticancer Therapies 55 Esophageal 55 Pulmonary Fibrosis PF 55 Sidney Kimmel Comprehensive Cancer 55 Randomized Study 55 Insulin Resistance 55 Gynecologic Cancer Society 55 Radiation Oncologists 55 Castration Resistant Prostate Cancer 55 Patients Suffering 55 ICAAC IDSA 55 Interventional Radiology SIR 55 Immunotherapeutics 55 Eye Diseases 55 Minimally Invasive Therapy 55 Prostate Cancer Patients 55 Prostate Cancer Survival 55 Islet Transplantation 55 Breast Oncology 55 Ozarelix 54 II Clinical Trial 54 Functional Neurosurgery 54 Cervical Cancer Screening 54 Juvenile Idiopathic Arthritis 54 pertuzumab 54 Endometrial Cancer 54 Digital Mammographic Imaging 54 UEGW 54 Prolongs Survival 54 Chronic Sinusitis 54 Toxicogenomics 54 Fetal Diagnosis 54 FDA Approves Drug 54 Enrolling Patients 54 Lupus Nephritis 54 Investigational Drug 54 UCSF Comprehensive Cancer 54 Minimally Invasive Procedure 54 Cholesterol Levels SPARCL 54 Vandetanib 54 UM Comprehensive Cancer 54 Prostate Screening 54 Previously Untreated 54 Cancer Therapeutic 54 Novel Treatments 54 Genital Infection 54 Gynecologic Oncology 54 Poster Discussion 54 RTOG 54 Squamous Cell 54 Tyrosine Kinase Inhibitors 54 Chronic Lymphocytic Leukemia CLL 54 CTRC AACR San Antonio 54 gynecological cancers 54 Stroke Prevention 54 Genitourinary Cancers Symposium 54 Antitumor Activity 54 Multiple Myeloma Patients 54 Brain Aneurysm 54 Prospective Randomized 54 ASTRO Annual Meeting 54 Improve Survival 54 Follicular Lymphoma 54 San Antonio Breast Cancer 54 Leukemias 54 Neuroendocrine 54 Neoadjuvant Chemotherapy 54 Neulasta ® 54 Adjuvant Breast Cancer 54 Cancer Detection 54 Robotic Assisted 54 EADV 54 Prostate Biopsy 54 Previously Treated 54 Jonsson Comprehensive Cancer 54 Genes Predict 54 Oncology ASTRO 54 gynecologic cancer 54 Relapsed Multiple Myeloma 54 AA Amyloidosis 54 Clinical Oncology Gastrointestinal Cancers 54 Heart Failure 54 Dermatological 54 Cognitive Deficits 54 Adjuvant Treatment 54 Fibroid 54 Lymphoma 54 Clinical Research 54 Epiphany Biosciences 54 CyberKnife Radiosurgery 54 hormone refractory metastatic prostate 54 Patients Treated 54 John Theurer Cancer 54 Radiation Oncology ASTRO 54 Cetuximab 54 gynecologic cancers 54 Advanced Ovarian Cancer 54 assessing T DM1 54 Pulmonary Arterial Hypertension 54 Phase III Clinical Trial 54 Diabetic Ulcers 54 Photodynamic Therapy 54 Vaccine Trials 54 Chronic Hepatitis C 54 Renal Anemia 54 Juvenile Arthritis 54 Preventive Oncology 54 Hematopoietic Stem Cell Transplantation 54 Ischemic 54 Randomized Phase 54 Biologic Therapy 54 Surgical Pathology 54 Pancreatic 54 Peripheral Neuropathy 54 Chronic HCV 54 Gynecologic Oncologists 54 RCW Breast Cancer 54 Congenital Heart Disease 54 Breast Cancer Symposium 54 Islet Transplant 54 Acute Myelogenous Leukemia 54 HNSCC 54 Urological 54 Prostate Cancer Risk 54 Related Cancers 54 Inflammatory Diseases 54 M.D. Ph.D. 54 atypical Hemolytic Uremic Syndrome 54 Vascular Diseases 54 Neurodegenerative Disease 54 Myelodysplastic Syndrome 54 EORTC NCI 54 Adult Stem Cell Therapy 54 Carotid Stenting 54 Breast Density 54 Nephrology Renal Week 54 Breast Surgery 54 Experimental Therapeutics Program 54 Friedreich Ataxia 54 Oncology 54 Colorectal Adenomas 54 Improves Survival 54 Anti Angiogenesis 54 Organ Transplantation 54 Cardiovascular Mortality 54 Exploratory Clinical 54 Phase 2b Clinical Trial 54 Cell Signalling 54 Hematology 54 Slow Progression 54 Autoimmune Disorders 53 Lung Diseases 53 Heart Transplant Recipients 53 Relapsed Refractory 53 Prostate Disease 53 Cancer AACR NCI 53 Advanced Heart Failure 53 Evaluation WISE 53 Dual Antiplatelet Therapy 53 Urologic Cancer 53 Peritoneal Mesothelioma 53 Uterine Fibroid Embolization 53 Improve Outcomes 53 Periodontal Disease 53 Non Invasive Treatment 53 Cell Transplants 53 Biotherapy 53 ovarian lung 53 Hemangioma 53 Solid Malignancies 53 Blood Cancers 53 Malignant Lymphoma 53 Antibody Therapeutics 53 Statin Therapy 53 Therapy Evaluation 53 Acute Renal Failure 53 Skin Disease 53 Lupus 53 Breast Cancer Screening 53 Invasive Breast Cancer 53 Brain Tumor Treatment 53 Treatment Shows Promise 53 LIJ Medical 53 Neurodegenerative 53 malignant pleural mesothelioma 53 Kidney Transplantation 53 Cognitive Function 53 Cancer Vaccine 53 Venous Thromboembolism 53 Hepatitis C Virus 53 Cervical Cancer 53 Neurological Disorder 53 Cardiac Stem Cell 53 AACR San Antonio 53 Lumbar Spine 53 Brain Tumor Research 53 Dupuytren Disease 53 Autoimmunity 53 Cystic Fibrosis 53 Knee Osteoarthritis 53 Advanced Colorectal Cancer 53 Maryland Greenebaum Cancer 53 Radical Prostatectomy 53 ANN INTERN MED 53 Non Melanoma Skin 53 Cell Lymphoma 53 Ovarian Cancers 53 Aneurysm Repair 53 Hormone Therapy 53 Subgroup Analysis 53 CombAT 53 See CLINICAL PHARMACOLOGY 53 Gene Mutation 53 Molecular Biomarkers 53 Therapeutics TCT 53 Glioma 53 Metastatic Renal Cell Carcinoma 53 Study Evaluating 53 Hyperlipidemia 53 Catheterization Laboratory 53 Endovascular Therapy 53 Stem Cell Transplants 53 Arterial Disease 53 Benign Prostatic Hyperplasia 53 AIR2 Trial 53 Preclinical Models 53 Epilepsy Surgery 53 Complicated Skin 53 Radiation Therapy 53 Therapeutic Radiation 53 Metastatic Pancreatic Cancer 53 Relapsing Multiple Sclerosis 53 Clinical Genetics 53 Endocrine Surgery 53 Enlarged Prostate 53 Osteoarthritis Patients 53 Neurological Diseases 53 Osteoporosis Treatment 53 Recurrent Chest Wall 53 Alessandro Riva 53 Arthritis Musculoskeletal 53 Coronary Revascularization 53 AACR #st Annual Meeting 53 Fluorouracil 53 Chronic Hepatitis B 53 Investigational Compound 53 Metabolic Diseases 53 fallopian tube carcinoma 53 Endothelial Dysfunction 53 Pivotal Phase III 53 transthyretin TTR mediated amyloidosis 53 Supportive Care 53 Jean Jacques Garaud 53 Buprenorphine Treatment 53 Systemic Lupus Erythematosus SLE 53 Treatment Approaches 53 AACR Meeting 53 Resuscitation Science 53 Immune Mediated 53 Female Urology 53 Kidney Cancer 53 RNAi Therapeutics 53 ALS MND 53 Thrombosis 53 Edge STudy 53 HFSA 53 Drug Combo 53 Clinical Oncology 53 Cellular Immunology 53 Treatment Naive Patients 53 receiving chemoradiation therapy 53 Gene Linked 53 Psoriasis Patients 53 Connective Tissue Oncology 53 CT Angiography 53 Paroxysmal Nocturnal Hemoglobinuria PNH 53 AACR NCI EORTC 53 Cardiovascular Research 53 Treatment Options 53 Adenoma 53 Hematology Annual Meeting 53 Improve Diagnosis 53 Cardiovascular Disease 53 Clinical Trials 53 Cancer Vaccines 53 Cystinosis 53 LSE ASM 53 Meets Primary Endpoint 53 Childhood Leukemia 53 Laryngeal Cancer 53 Aortic Stenosis 53 Cystectomy 53 HuMax EGFr 53 Complete Remission 53 Breast Tumor 53 Image Guided 53 Benign Prostatic Hyperplasia BPH 53 Rheumatoid Arthritis 53 Drug Prevents 53 ACRIN 53 Randomized Phase II 53 Diabetes Endocrinology 53 Celiac Research 53 Minimally Invasive Spine Surgery 53 Drug Eluting 53 ISPOR 53 Clinical Oncology Annual Meeting 53 Thrombotic 53 Lung Cancer IASLC 53 Pelvic Surgery 53 Genetic Disease 53 Breast Cancer Risk 53 registrational Phase 53 Genetic Testing 53 Renal Artery 53 pancreatic islet cell 53 Cholangiocarcinoma 53 Daniel Von Hoff 53 relapsed leukemia 53 Hemodialysis Patients 53 Cognitive Impairment 53 Cytology 52 Oral Mucositis 52 gynecological cancer 52 Successfully Treated 52 CROI 52 Tumor Microenvironment 52 Prostate Cancer ERSPC 52 AUA Annual Meeting 52 Abiraterone Acetate 52 Cancer Stem Cells 52 MD FACS FAAP 52 Renal Cell Carcinoma RCC 52 Radiofrequency Ablation 52 Oral Cancer 52 Fibrosis 52 Immunobiology 52 Combination Treatment 52 Pemetrexed 52 Marrow Transplantation 52 metastatic gastric 52 Testicular Cancer 52 Localized Prostate Cancer 52 Myeloma Patients 52 Carcinoma 52 Psoriasis 52 Barrett Esophagus 52 Alzheimers Disease 52 Clinical Outcomes 52 Venous Thrombosis 52 Molecular Pathogenesis 52 chronic myeloid 52 UCLA Jonsson Cancer 52 Monotherapy 52 Human Neural Stem 52 Cachexia 52 Artery Disease 52 Neurodegenerative Disorders 52 LivingWell Cancer Resource 52 Treating Chronic 52 neoadjuvant treatment 52 Molecular Origins 52 OHSU Cancer 52 Fabry Disease 52 Cell Lung Cancer 52 Early Lung Cancer 52 #nd EORTC NCI 52 Chemoradiation 52 Protein Therapeutics 52 Newly Diagnosed 52 PROSTATE CANCER 52 Oncology ESTRO 52 Breast Disease 52 Cancer Therapeutics 52 MEK Inhibitor 52 Anti Tumor Activity 52 Obese Patients 52 NCI Cancer 52 pancreatic adenocarcinoma 52 Oncology Hematology 52 Rheumatoid Arthritis RA 52 Anti Tumor 52 Hematologist 52 Multicenter Phase 52 Mitral Valve Repair 52 Pivotal Trial 52 Idiopathic Pulmonary Fibrosis 52 Colposcopy 52 Brain Disorders 52 Scleroderma Research 52 Pancreas Transplant 52 Restless Leg Syndrome 52 Pleural Mesothelioma 52 Metastatic Cancer 52 Skin Lesions 52 Atypical Hemolytic Uremic Syndrome 52 Randomized Phase III 52 Liver EASL 52 cetuximab Erbitux 52 Decitabine 52 chemotherapy FOLFOX 52 Urology EAU 52 Comprehensive Cancer Center 52 Elderly Patients 52 Breast Cancer Survivors 52 Peripheral Arterial 52 Genes Identified 52 Nymox NX 52 Stroke Survivors 52 Migraine Headaches 52 Hepatocellular 52 Acute Ischemic Stroke 52 Relapsed Refractory Multiple Myeloma 52 Myelofibrosis 52 Integrative Oncology 52 Pituitary 52 Slows Progression 52 Angiology 52 Refractory Angina 52 IASLC 52 Batten Disease 52 Autologous Stem Cell 52 Sustained Efficacy 52 Eculizumab 52 Myelodysplastic Syndromes MDS 52 Oral Presentations 52 Craniofacial 52 Cardiology ESC Congress 52 Targeted Therapy 52 Lung Cancer Treatment 52 Pirfenidone 52 Hepatobiliary 52 Treatment Reduces 52 Perinatal Depression 52 Cancer Diagnosis 52 Contrast Agent 52 Acute Coronary Syndromes 52 Molecular Diagnostic 52 Ovarian PLCO Cancer 52 Diabetic Kidney Disease 52 Lymphoma Research 52 Cytopathology 52 Pediatric Neurosurgery 52 Adenoid Cystic Carcinoma 52 Preclinical Development 52 Personalised Medicine 52 Diabetes Complications 52 Respiratory Syncytial Virus 52 Prostate Lung Colorectal 52 Estrogen Therapy 52 CIPN 52 Well Tolerated 52 Breast Cancer Diagnosis 52 Interstitial Lung Disease 52 Lung Disease 52 Anticancer Drugs 52 REMINDER ORLive Presents 52 Pancreas 52 Clinical Trials Consortium 52 Renal Failure 52 Placebo Controlled Study 52 Chicago Multidisciplinary Symposium 52 Herceptin trastuzumab 52 Reducing Health Disparities 52 Boosts Survival 52 Phase 2b Study 52 Solid Cancers 52 relapsed multiple myeloma 52 Multicenter Trial 52 Ovarian Cancer Screening 52 Duke Translational Medicine 52 Arteriosclerosis 52 Molecular Markers 52 Dendritic Cells 52 Randomized Double Blind 52 solid organ transplantation 52 Dose Escalation 52 Gaucher Disease 52 Cleft Palate 52 Kidney Transplants 52 Hemorrhagic Stroke 52 Predict Risk 52 recurrent glioblastoma multiforme 52 ThermoDox R 52 Newly Diagnosed Breast Cancer 52 Cell Therapy 52 Digestive Diseases Week 52 Safinamide 52 Nesiritide 52 Alzheimer Disease 52 Treatment Outcomes 52 Preclinical Efficacy 52 Fertility Treatment 52 Colorectal Screening 52 Bleeding Disorder 52 Treatment Resistant 52 Premenopausal Women 52 Epilepsy 52 aflibercept 52 Renata Pasqualini 52 Hsp# Inhibitor 52 Screening Trial 52 Neuromuscular Disease 52 Cystic 52 Myelodysplastic Syndromes Foundation 52 CYT# potent vascular disrupting 52 Gynecologic Oncology Group 52 Transplant Patients 52 Stenting 52 Diabetic Foot Ulcer 52 Hospital Acquired Pneumonia 52 RNAi Therapeutic 52 Pegylated Interferon 52 Kidney Failure 52 TTF Therapy 52 Pediatric Diabetes 52 Susceptibility Gene 52 Anticoagulation 52 Viral Infections 52 Robotic Surgery 52 recurrent NSCLC 52 Periodontal Diseases 52 Less Invasive 52 Carotid Endarterectomy 52 Aortic Dissection 52 Congenital Heart 52 Patient Enrollment 52 Metastatic Colon Cancer 52 Interventional Radiology 52 Melanoma Skin Cancer 52 Initiates Phase III 52 CTRC AACR 52 Antithrombotic 52 Intravenous Formulation 52 Carboplatin Paclitaxel 52 Genitourinary Oncology 52 Omacetaxine 52 LBH# 52 Michigan Comprehensive Cancer 52 Late Breaker 52 Node Negative 52 metastatic androgen independent 52 Memory Disorders 52 Capsule Endoscopy 52 CALGB 52 RNA Therapeutics 52 Biomarker 52 BCIRG 52 Frontotemporal Dementia 52 Neuromuscular Disorders 52 Amrubicin 52 Cervical Dysplasia 51 Cervical Pathology 51 OVARIAN 51 Inflammatory Breast Cancer 51 Chemoprevention 51 Hereditary Cancer 51 ZACTIMA 51 Taxotere ® 51 Glioblastoma Multiforme 51 Regenerative Cell 51 DNA Sequencing 51 Antiangiogenic 51 Osteoporosis Drugs 51 Hospitalized Patients 51 Pancreas Cancer 51 Molecular Oncology 51 colorectal cancer CRC 51 Metastatic Disease 51 Female Sexual Arousal 51 Cartilage Repair 51 NSABP 51 Atherosclerosis 51 Imaging Diagnostic 51 Skull Base 51 Pharmacogenetic 51 Liver Transplant Program 51 Breast Carcinoma 51 Hepatitis C Infection 51 Osteoporosis Drug 51 Bone Metastases 51 Bone Fractures 51 Psychiatric Disorders 51 Asthma Clinical 51 Coronary Heart Disease 51 Node Positive 51 Phase III Trials 51 decitabine 51 Cellular Therapy ISCT 51 Mouse Models 51 Serious Infections 51 Cardiovascular Disease Risk 51 Kidney Stones 51 Treating Prostate Cancer 51 severe oral mucositis 51 Meningiomas 51 Malignant Glioma 51 Surgery Performed 51 Clinical Oncologists 51 Preterm Birth 51 Dialysis Outcomes 51 Interventional Neuroradiology 51 SCCHN 51 Genetic Variation 51 Retrovirus 51 Cardiac Resynchronization Therapy 51 Kidney Transplant Recipients 51 Jeffrey Modell 51 hepatocellular cancer 51 ARVO 51 Spine Surgery 51 Atherosclerosis Research 51 Valve Replacement 51 Virtual Colonoscopy 51 Excessive Sweating 51 Venous Forum 51 Osteoporosis Screening 51 bladder ovarian 51 Gynecological Cancers 51 Cellular Therapy 51 ST Segment Elevation 51 Lung Cancer Drug 51 Hematology Molecular Pathology 51 metastatic malignant 51 Temodar ® 51 Adenomas 51 Carcinomas 51 Human Genetics ASHG 51 Predict Breast Cancer 51 Relapsed Refractory Aggressive 51 Minimally Invasive 51 Inflammatory Markers 51 Melanoma 51 Liver Transplants 51 Randomized Comparison 51 Renal Function 51 Tumor Immunology 51 Adefovir 51 BIOCOM Investor Conference 51 Xelox 51 UroToday.com 51 Ankylosing Spondylitis 51 Prognostic Factors 51 Basal Cell 51 Ahmanson UCLA Cardiomyopathy 51 Spine Patient Outcomes 51 TORS 51 Trastuzumab 51 Phase 2b Trial 51 ECCO ESMO 51 Monoclonal Antibodies 51 Percutaneous Coronary Intervention 51 Preterm Delivery 51 Pediatric Cardiac 51 Coronary Arteries 51 Clinical Efficacy 51 Sorafenib 51 commercialize deforolimus 51 Colon Rectal 51 Genetic Markers 51 Recurrent Prostate Cancer 51 Pathology Informatics 51 Experimental Vaccine 51 Recurrences 51 Osteoporotic 51 Spinal Surgery 51 Nilotinib 51 Amgen Vectibix 51 Gastrointestinal Cancers Symposium 51 Velcade bortezomib 51 Breast Cancer Treatments 51 Erectile Dysfunction Drug 51 Transcatheter 51 Proxinium TM 51 Fungal Infections 51 developer Antisoma plc 51 Arrhythmias 51 Hydroxyurea 51 lung liver pancreas 51 gastrointestinal malignancies 51 Anticancer Agent 51 Sjogren Syndrome 51 Chronic Pelvic Pain 51 Novel Therapeutic 51 Focal Therapy 51 AIDS Vaccine 51 Knee Arthritis 51 Ovarian Cancer Treatment 51 Percutaneous Cardiovascular Interventions 51 Patients Undergoing 51 Antiplatelet Therapy 51 ST Elevation Myocardial 51 Disease Progression 51 Effective Treatments 51 TTR amyloidosis 51 Drug Shows Promise 51 Angiographic 51 Institut Jules Bordet 51 Pivotal Clinical Trial 51 lymphoma leukemia 51 YONDELIS 51 Cardiac Catheterization 51 Chronic Kidney 51 Glycemic Control 51 Thrombophilia 51 Blocked Arteries 51 Chronic Kidney Disease 51 Sapacitabine 51 Radiation Therapy Oncology 51 Feist Weiller Cancer 51 AASLD 51 NCI Comprehensive Cancer 51 Endocrine Society Annual Meeting 51 Cancer MASCC 51 Hematology ASH Annual Meeting 51 ABRF 51 TRO# 51 Mood Disorder 51 Demonstrates Potent 51 Hand Transplant 51 Clinical Microbiology 51 Schizophrenia Treatment 51 Neck Surgery Foundation 51 Transplant Patient 51 Alteplase 51 Reproductive Biology 51 Nerve Regeneration 51 Malaria Vaccine 51 Gene Therapy ASGT 51 Basal Cell Carcinoma 51 Aggressive Prostate Cancer 51 Lung Transplant 51 st Annual Meeting 51 Myeloproliferative Disorders 51 Orthopaedic Trauma 51 EORTC NCI AACR 51 Investigator Initiated 51 Asthma Treatment 51 Nephrology ASN Renal 51 Neural Therapy 51 Randomized Controlled 51 Neck Surgery 51 Nicotine Vaccine 51 Anticoagulant 51 Stent Placement 51 erythematosus 51 Cosmetic Plastic Surgery 51 Resistant Hypertension